Antisense antiviral agent and method for treating ssrna viral infection
CA 2463641 C · Owner: Smith, Alvin W. · Inventors: Skilling, Douglas E.; Smith, Alvin W.; Iversen, Patrick L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides antisense antiviral compounds and methods of their use in inhibition of growth of viruses of the picornavirus calicivirus, togavirus , and flavivirus families as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a targeting base sequence that is substantially complementary to a viral target sequence which spans the AUG start site of the first open reading frame of the viral genome.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 16, 2002 and granted July 9, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.